Article and Video CATEGORIES

Cancer Journey

Search By

ABOUT
Denise Brock

Denise has over 30 years of varying experience in the healthcare arena.  In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees.  She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.  

 

Applications are now closed!... Be a Part of the Patient Perspectives: Clinical Trials Storytelling Program - 2024-25
Applications have closed for this program. Keep your eye on next year to be a part of this paid program - Patient Perspectives: Clinical Trials Experiences - Storytelling Program - 2024-25
Author
Denise Brock
Image
2024-25 patient perspectives header
Tell your story and help us help others!

The application process is now closed.  Thank you for your interest! 

 


 

GRACE Patient Perspectives:  Clinical Trials Storytelling Program - 2024-25 - Overview

 

The goal of this Patient Perspectives program is to give a voice to those who have experience in participating in a clinical trial for a cancer diagnosis.  By telling your story, you can educate others on the process, discuss your difficulties, and share your accomplishments.  Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial.  This is a paid opportunity and you will receive a stipend for your participation!
 

Storytelling will take the form of written, video, and/or audio/podcast to reach the largest audience.  GRACE staff will coach and support participants on digital outreach and advocacy. 

 

All people currently enrolled in, or with past enrollment in, a clinical trial for a cancer diagnosis are welcome and encouraged to apply. GRACE’s designated committee will review the nominees and select up to 3 applicants for participation in the 2024-25 program.

 

Who is GRACE?

 

The Global Resource for Advancing Cancer Education (GRACE, cancerGRACE.org) is a non-profit organization founded by leading Thoracic Oncologist, Dr. Howard (Jack) West, in 2007.  GRACE’s mission is to provide expert-mediated information directly to people with a cancer diagnosis and their caregivers to empower them to become direct partners in their cancer treatment.  We currently produce over 300 short videos each year, reaching our community in over 190 countries. 

 

Benefits of Participation

 

Applicants selected for this year’s program will work closely with GRACE staff to develop new educational content and learn new communication skills through the storytelling process.
Participants will receive training on digitally distributed content, social media, and other platforms.  Participants' work will be highlighted and shared by GRACE, our network of established leaders in the oncology community, and GRACE board members with an array of interests and connections.    

Participants will receive a stipend, training in communication and media platforms and a tech ‘package’.  

 

Expectations

 

Participants will work with GRACE to develop program formats and production and will present a proposal based on their experience in a clinical trial program.  Participants will be expected to attend (via ZOOM) regular meetings throughout the program year to learn and to discuss their ideas. A minimum of three (3) media productions per participant will be expected by the end of the program.  
 

Ideal Candidates

 

People who are navigating a cancer diagnosis, who are currently or have been involved in a clinical trial, and who have a passion for helping others and telling their stories are ideal for this program.  

 

Applicants should have a particular interest and passion for communications, sharing experiences, storytelling, and patient education.  People looking for a way to give back to the cancer community, who exhibit strong written and oral communication skills coupled with a passion for sharing experiences to educate and advocate will thrive in this program.   GRACE will guide them through boosting their voice to advocate for themselves and others in the cancer community.     

 

2024 is our fourth year for this program, and we are excited to continue to generate a platform for patient advocacy and sharing patient education in the area of clinical trials.  
 

The application due date has been extended to October 25, 2024 for consideration. Applicants will be contacted by November 8, 2024, with information regarding acceptance and the next steps.

To apply online please click here OR download the above attached pdf form and email it to dbrock@cancerGRACE.org.


Any questions, please contact Denise Brock at dbrock@cancergrace.org or 888-501-1025 x2.
 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
Advance directives are a powerful way to take control of healthcare choices. These documents allow you to outline preferences for medical care and specify end-of-life wishes. These documents can also be a way to appoint loved ones who you would like to help with these decisions, such as a healthcare proxy (someone to make decisions on your behalf, if you cannot). As cancer treatments can involve aggressive treatments and/or complex medical management, having advance directives ensures that your desires regarding treatment options and end-of-life care are clearly communicated. 
Image
Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón
Video
¡El vídeo completo bajo demanda está disponible para verlo!

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Recent Comments

JOIN THE CONVERSATION
That's beautiful Linda…
By JanineT GRACE … on
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on